PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Endocrinology and Metabolism10.3803/enm.2019.34.2.1502019342150Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid CancerMyung-Chul Lee, Min Joo Kim, Hoon Sung Choi, Sun Wook Cho, Guk Haeng Lee, Young Joo Park, Do Joon Parkhttps://synapse.koreamed.org/pdf/10.3803/EnM.2019.34.2.150, https://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2019.34.2.150, https://synapse.koreamed.org/DOIx.php?id=10.3803/EnM.2019.34.2.150
10.21203/rs.3.rs-818671/v12021Thyroid Stimulating Hormone Suppression and Recurrence After Thyroid Lobectomy For Papillary Thyroid CarcinomaMi Rye Bae, Sung Hoon Nam, Jong-Lyel Roh, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kimhttps://www.researchsquare.com/article/rs-818671/v1, https://www.researchsquare.com/article/rs-818671/v1.html
Endocrine10.1007/s12020-021-02911-x2021Thyroid stimulating hormone suppression and recurrence after thyroid lobectomy for papillary thyroid carcinomaMi Rye Bae, Sung Hoon Nam, Jong-Lyel Roh, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kimhttps://link.springer.com/content/pdf/10.1007/s12020-021-02911-x.pdf, https://link.springer.com/article/10.1007/s12020-021-02911-x/fulltext.html, https://link.springer.com/content/pdf/10.1007/s12020-021-02911-x.pdf
Thyroid10.1089/thy.2021.04042021Optimal serum thyroid-stimulating hormone level for patients with papillary thyroid carcinoma after lobectomysiyuan xu, ying huang, hui huang, xiaohang zhang, jiaxin qian, xiaolei wang, zhengang Xu, shaoyan liu, Jie Liuhttps://www.liebertpub.com/doi/pdf/10.1089/thy.2021.0404
Clinical Endocrinology10.1111/cen.145802021Is thyroid hormone supplementation avoidable for patients with low‐risk papillary thyroid cancer after thyroid lobectomy? A two‐center observational studyLiu Xiao, Jie Wu, Lisha Jiang, Yangmengyuan Xu, Bin Liuhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.14580, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cen.14580, https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.14580
Thyroid10.1089/thy.2009.03322010206607-613Oncofetal Fibronectin mRNA Is Highly Abundant in the Blood of Patients with Papillary Thyroid Carcinoma and Correlates with High-Serum Thyroid-Stimulating Hormone LevelsMichael Wehmeier, Thorsten Petrich, Korbinian Brand, Ralf Lichtinghagen, Eric Hessehttps://www.liebertpub.com/doi/full-xml/10.1089/thy.2009.0332, https://www.liebertpub.com/doi/pdf/10.1089/thy.2009.0332
Clinical Thyroidology10.1089/ct.2021;33.497-49920213311497-499A Possible Role for Serum Thyroglobulin to Predict Structural Recurrence of Papillary Thyroid Cancer After Thyroid LobectomyAashka Shah, Spyridoula Marakahttps://www.liebertpub.com/doi/full-xml/10.1089/ct.2021%3B33.497-499, https://www.liebertpub.com/doi/pdf/10.1089/ct.2021%3B33.497-499
Thyroid10.1089/thy.2012.0183201222101007-1015Recombinant Human Thyroid Stimulating Hormone–Assisted Radioactive Iodine Remnant Ablation in Thyroid Cancer Patients at Intermediate to High Risk of RecurrenceJonathan Hugo, Eyal Robenshtok, Ravinder Grewal, Steve Larson, R. Michael Tuttlehttps://www.liebertpub.com/doi/full-xml/10.1089/thy.2012.0183, https://www.liebertpub.com/doi/pdf/10.1089/thy.2012.0183
Thyroid10.1089/thy.2021.06172021Optimal TSH following lobectomy for papillary thyroid cancer: Does it exist?Lindsay Bischoff, Megan R. Haymarthttps://www.liebertpub.com/doi/pdf/10.1089/thy.2021.0617
Clinical Thyroidology10.1089/ct.2018;30.312-3142018307312-314Thyroglobulin Levels Do Not Predict Recurrence After Lobectomy for Low-Risk Papillary Thyroid CancerMasha J. Livhits, Michael W. Yehhttp://www.liebertpub.com/doi/full-xml/10.1089/ct.2018%3B30.312-314, http://www.liebertpub.com/doi/pdf/10.1089/ct.2018%3B30.312-314